SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Epigral - Quaterly Results

31 Jan 2026 Evaluate
The sales declined to Rs. 5971.20 millions for the December 2025 quarter as compared to Rs. 6452.40 millions during the corresponding quarter last year.A big decline of -62.19% was reported for the quarter ended December 2025 to Rs. 391.50  millions from Rs. 1035.40 millions of corresponding previous quarter.Operating Profit reported a sharp decline to 1083.00 millions from 1863.70 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 5971.20 6452.40 -7.46 17910.20 19225.00 -6.84 25501.30 19291.90 32.19
Other Income 55.60 38.60 44.04 155.50 118.10 31.67 152.10 65.20 133.28
PBIDT 1083.00 1863.70 -41.89 4140.40 5491.50 -24.60 7259.30 4877.20 48.84
Interest 109.50 -0.70 -15742.86 561.60 415.00 35.33 532.70 734.90 -27.51
PBDT 973.50 1864.40 -47.78 3578.80 5076.50 -29.50 6726.60 4142.30 62.39
Depreciation 427.50 329.10 29.90 1266.00 986.10 28.38 1325.60 1235.60 7.28
PBT 546.00 1535.30 -64.44 2312.80 4090.40 -43.46 5401.00 2906.70 85.81
TAX 154.50 499.90 -69.09 -198.00 1389.60 -114.25 1834.00 948.80 93.30
Deferred Tax 19.40 119.50 -83.77 -762.60 558.30 -236.59 852.30 421.70 102.11
PAT 391.50 1035.40 -62.19 2510.80 2700.80 -7.03 3567.00 1957.90 82.18
Equity 431.40 431.40 0.00 431.40 431.40 0.00 431.40 415.50 3.83
PBIDTM(%) 18.14 28.88 -37.21 23.12 28.56 -19.07 28.47 25.28 12.60

Epigral Share Price

1194.20 24.90 (2.13%)
22-Apr-2026 13:01 View Price Chart
Peers
Company Name CMP
BASF India 3741.70
Tata Chemicals 710.60
SRF 2500.95
Pidilite Inds. 1411.50
Deepak Nitrite 1724.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×